Risk Factors for Skin Flap Necrosis in Breast Cancer Patients Treated with Mastectomy Followed by Immediate Breast Reconstruction.
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
pubmed:
15
11
2018
medline:
27
6
2019
entrez:
15
11
2018
Statut:
ppublish
Résumé
Skin-sparing mastectomy (SSM) and nipple-sparing mastectomy (NSM) are the standard techniques for achieving a cosmetic outcome, but necrosis of a cutaneous flap including the nipple-areolar complex (NAC) is a serious complication. To analyze the risk factors for skin flap necrosis, we retrospectively evaluated a clinical database of breast cancer patients treated with mastectomy followed by immediate breast reconstruction. Four hundred and twelve cases were consecutively recorded between 2006 and 2016. Body weight (BW), body mass index (BMI), distance from NAC to referent tumor, distance from overlying skin to the tumor and weight of breast resection (WBR) as measured in the operating theater were included in the statistical analysis. NSM, SSM and total mastectomy were performed in 123 (30%), 96 (23%) and 193 cases (47%), respectively. A tissue expander was used in 379 cases (92%), a silicone implant in 8 (2%) and autologous breast reconstruction in 25 (6%). Skin flap necrosis was found in 7% of all cases and NAC necrosis in 13% of NSM cases. In a univariate analysis, BW, NSM and WBR were risk factors for skin flap necrosis, and BW, BMI and WBR were risk factors for NAC necrosis. In a multivariate analysis, NSM and WBR remained significant risk factors for skin flap necrosis, and WBR was a significant risk factor for NAC necrosis. WBR is an important risk factor for skin flap necrosis. Especially, NAC necrosis should be considered for patients with large-volume breasts who undergo NSM and immediate breast reconstruction.
Sections du résumé
BACKGROUND
BACKGROUND
Skin-sparing mastectomy (SSM) and nipple-sparing mastectomy (NSM) are the standard techniques for achieving a cosmetic outcome, but necrosis of a cutaneous flap including the nipple-areolar complex (NAC) is a serious complication. To analyze the risk factors for skin flap necrosis, we retrospectively evaluated a clinical database of breast cancer patients treated with mastectomy followed by immediate breast reconstruction.
METHODS
METHODS
Four hundred and twelve cases were consecutively recorded between 2006 and 2016. Body weight (BW), body mass index (BMI), distance from NAC to referent tumor, distance from overlying skin to the tumor and weight of breast resection (WBR) as measured in the operating theater were included in the statistical analysis.
RESULTS
RESULTS
NSM, SSM and total mastectomy were performed in 123 (30%), 96 (23%) and 193 cases (47%), respectively. A tissue expander was used in 379 cases (92%), a silicone implant in 8 (2%) and autologous breast reconstruction in 25 (6%). Skin flap necrosis was found in 7% of all cases and NAC necrosis in 13% of NSM cases. In a univariate analysis, BW, NSM and WBR were risk factors for skin flap necrosis, and BW, BMI and WBR were risk factors for NAC necrosis. In a multivariate analysis, NSM and WBR remained significant risk factors for skin flap necrosis, and WBR was a significant risk factor for NAC necrosis.
CONCLUSIONS
CONCLUSIONS
WBR is an important risk factor for skin flap necrosis. Especially, NAC necrosis should be considered for patients with large-volume breasts who undergo NSM and immediate breast reconstruction.
Identifiants
pubmed: 30426185
doi: 10.1007/s00268-018-4852-y
pii: 10.1007/s00268-018-4852-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
846-852Références
N Engl J Med. 2002 Oct 17;347(16):1227-32
pubmed: 12393819
N Engl J Med. 2002 Oct 17;347(16):1233-41
pubmed: 12393820
Arch Surg. 2004 Feb;139(2):148-50
pubmed: 14769571
World J Surg. 2006 Aug;30(8):1410-3
pubmed: 16850148
J Am Coll Surg. 2006 Nov;203(5):704-14
pubmed: 17084333
J Clin Oncol. 2007 Jan 1;25(1):118-45
pubmed: 17159189
Surgery. 2008 Mar;143(3):414-25
pubmed: 18291263
Ann Surg. 2009 Jan;249(1):26-32
pubmed: 19106672
Ann Surg. 2009 Mar;249(3):461-8
pubmed: 19247035
Plast Reconstr Surg. 2009 Jun;123(6):1665-73
pubmed: 19483564
Ann Surg. 2010 Apr;251(4):632-9
pubmed: 20224371
J Surg Oncol. 2010 Jul 1;102(1):39-42
pubmed: 20578076
Breast. 2011 Feb;20(1):21-5
pubmed: 20619645
Eur J Surg Oncol. 2012 Feb;38(2):125-9
pubmed: 22056645
Ann Surg Oncol. 2012 Dec;19(13):4117-23
pubmed: 22820937
Ann Surg Oncol. 2013 Mar;20(3):990-6
pubmed: 23070785
Ann Surg Oncol. 2016 Jan;23(1):257-64
pubmed: 26193963
Eur J Cancer. 2015 Sep;51(14):1882-9
pubmed: 26210374
Arch Plast Surg. 2015 Sep;42(5):601-7
pubmed: 26430632
Breast Cancer. 2016 Nov;23(6):851-860
pubmed: 26464007
World J Surg. 2016 Aug;40(8):2028-35
pubmed: 26956902
Ann Surg Oncol. 2016 Nov;23(12):4080-4085
pubmed: 27464608
Breast J. 2017 Jul;23(4):415-420
pubmed: 28097778
Breast Cancer (Dove Med Press). 2017 Mar 13;9:141-152
pubmed: 28331365
Plast Reconstr Surg. 2017 Jul;140(1):1e-8e
pubmed: 28654583